CohBar, Inc

(NASDAQ:CWBR)

Latest On CohBar, Inc (CWBR):

Date/Time Type Description Signal Details
2023-05-23 11:22 ESTNewsCohBar surges ~130% on proposed merger with cancer vaccine developer MorphogenesisN/A
2022-11-12 03:41 ESTNewsCohBar, Inc. (CWBR) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 04:40 ESTNewsCohBar GAAP EPS of -$0.82N/A
2022-09-22 16:17 ESTNewsCohBar stock gains on 1-for-30 reverse stock splitN/A
2022-08-16 06:37 ESTNewsCohBar GAAP EPS of -$0.03 beats by $0.01N/A
2022-08-16 06:37 ESTNewsCohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call TranscriptN/A
2022-05-17 05:32 ESTNewsCohBar GAAP EPS of -$0.04 in-lineN/A
2022-05-17 05:31 ESTNewsCohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 14:32 ESTNewsCohBar Q1 2022 Earnings PreviewN/A
2022-05-12 16:11 ESTNewsCohBar gets 180-day extension to regain compliance with Nasdaq listing ruleN/A
2022-03-30 00:20 ESTNewsCohBar GAAP EPS of -$0.04 beats by $0.01N/A
2022-03-30 00:20 ESTNewsCohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call TranscriptN/A
2021-12-17 21:16 ESTNewsCohBar announces changes to board of directors, resignation of CSON/A
2021-11-15 23:36 ESTNewsCohBar EPS beats by $0.03N/A
2021-11-15 23:36 ESTNewsCohBar, Inc. (CWBR) CEO Joe Sarret on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-28 19:44 ESTNewsCohBar slumps ~32% on pricing of ~$15M stock, warrants offeringN/A
2021-10-27 16:58 ESTNewsCohBar slumps in trade on launching stock and warrants offeringN/A
2021-10-12 23:29 ESTNewsWarning: CWBR is at high risk of performing badlyN/A
2021-10-07 08:29 ESTNewsCWBR is at high risk of performing badlyN/A
2021-09-27 16:04 ESTNewsWarning: CWBR has been downgraded to Very BearishN/A
2021-09-21 16:05 ESTNewsWarning: CWBR has been downgraded to Very Bearish.N/A
2021-08-10 23:25 ESTNewsCohBar shares rise 10% on topline results from early-stage NASH studyN/A
2021-08-10 23:24 ESTNewsCohBar's (CWBR) CEO Joe Sarret on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 03:40 ESTNewsCohBar shares drop on early-stage CB4211 data timeline updateN/A
2021-04-27 15:22 ESTNewsCohBar appoints Joseph Sarret as CEO and DirectorN/A
2021-04-24 08:13 ESTNewsCohBar: A Promising Early Pureplay On Mitochondrial-Based TherapeuticsN/A
2021-03-31 00:00 ESTNewsCohBar Q4 EPS misses by $0.03N/A
2021-03-31 00:00 ESTNewsCohBar, Inc. (CWBR) CEO Steve Engle on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-31 00:00 ESTNewsCohBar, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-17 16:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.38 to $6.3.Neutral
2021-01-11 16:41 ESTNewsCohBar collaborates with NIAID for CB5064 analogs in COVID-19-related ARDSN/A
2020-12-18 03:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $6.38.Neutral
2020-12-13 03:47 ESTFinancialsCompany financials have been released.Neutral
2020-11-22 17:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 19:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 11:50 ESTNewsCohBar, Inc. (CWBR) CEO Steve Engle on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-17 11:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 06:07 ESTNewsCohBar EPS in-lineN/A
2020-11-17 06:06 ESTNewsCohBar, Inc. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-17 03:42 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on March 31, 2021.N/A
2020-11-07 15:34 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:42 ESTAnalyst RatingThe Analyst Target Price has decreased from $8 to $7.5.Neutral
2020-09-26 12:30 ESTFinancialsCompany financials have been released.Neutral
2020-09-23 00:41 ESTEarnings EstimateAn EPS average of -$0.22 is estimated for the 2021 year.Sell
2020-09-23 00:41 ESTEarnings EstimateAn EPS average of -$0.29 is estimated for the 2020 year.Sell
2020-09-23 00:41 ESTEarnings EstimateAn EPS average of -$0.05 is estimated for the quarter ending on September 30, 2020.Buy
2020-09-23 00:41 ESTAnalyst RatingThe Analyst Target Price has increased from $0 to $8.Buy
2020-09-17 04:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-04 09:04 ESTInsider TradeMisha Petkevich has indirectly acquired of 11,000 shares.Buy
2020-09-03 09:19 ESTInsider TradeMisha Petkevich has indirectly acquired of 6,000 shares.Buy

About CohBar, Inc (CWBR):

CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular, and neurodegenerative diseases, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial-derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases, CB5064 analogs for COVID-19 associated ARDS, MBT5 analogs for CXCR4-related cancer and orphan diseases, and MBT3 analogs for cancer immunotherapy. The company was founded in 2007 and is headquartered in Menlo Park, California.

CWBR Quotes by TradingView

See Advanced Chart

General

  • Name CohBar, Inc
  • Symbol CWBR
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 12
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.cohbar.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 5.26
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.08
  • Return on Assets -39%
  • Return on Equity -102%
  • Earnings Per Share -$0.35
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 91.68 million
  • EBITDA -14262793
  • Analyst Target Price $6.3
  • Book Value Per Share $0.33
View More

Share Statistics

  • Shares Outstanding 61.12 million
  • Shares Float 45.14 million
  • % Held by Insiders 2448%
  • % Held by Institutions 12.34%
  • Shares Short 2.76 million
  • Shares Short Prior Month 2.87 million
  • Short Ratio 2.89
  • Short % of Float 6%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 2.72
  • 52 Week High $4.25
  • 52 Week Low $0.87
  • 50 Day Moving Average 1.66
  • 200 Day Moving Average 1.29
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

CohBar, Inc (CWBR) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

CohBar, Inc (CWBR) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.06-$0.05-20%
2020-06-302020-08-13$N/A-$0.09-$0.06-50%
2020-03-312020-05-14$N/A-$0.10
2019-12-312020-03-12$N/A-$0.09
2019-09-302019-11-06$N/A-$0.08
2019-06-302019-08-07$N/A-$0.07
2019-03-312019-05-07$N/A-$0.07
2018-12-312018-12-31$N/A-$0.10
2018-09-302018-09-30$N/A-$0.11
2018-06-302018-06-30$N/A-$0.08
2018-03-312018-03-31$N/A-$0.09
2017-12-312017-12-31$N/A-$0.07
2017-09-302017-09-30$N/A-$0.07
2017-06-302017-06-30$N/A-$0.05
2017-03-312017-03-31$N/A-$0.06
2016-12-312016-12-31$N/A-$0.05
2016-09-302016-09-30$N/A-$0.05
2016-06-302016-06-30$N/A-$0.05
2016-03-312016-03-31$N/A-$0.04
2015-12-312015-12-31-$0.04
2015-09-302015-09-30$N/A-$0.03
2015-06-302015-06-30$N/A-$0.03
2015-03-312015-03-31$N/A-$0.03

CohBar, Inc (CWBR) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

CohBar, Inc (CWBR) Chart:

CWBR chart by TradingView

CohBar, Inc (CWBR) News:

Below you will find a list of latest news for CohBar, Inc (CWBR) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

CohBar, Inc (CWBR) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest CWBR Trades:

Date Shares Price
Jun 13, 2022 1:39 PM EST100$0.2207
Jun 13, 2022 1:47 PM EST100$0.2012
Jun 13, 2022 7:58 PM EST100$0.2056

CohBar, Inc (CWBR) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-08-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1522602/000000000020008182/0000000000-20-008182-index.htm
2020-09-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1522602/000091957420005725/0000919574-20-005725-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390019014802/0001213900-19-014802-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1522602/000121390019015060/0001213900-19-015060-index.htm
2019-10-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019020813/0001213900-19-020813-index.htm
2019-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019020814/0001213900-19-020814-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390019020867/0001213900-19-020867-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019021510/0001213900-19-021510-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019021625/0001213900-19-021625-index.htm
2019-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019021801/0001213900-19-021801-index.htm
2019-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019022202/0001213900-19-022202-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390019022204/0001213900-19-022204-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1522602/000121390019022339/0001213900-19-022339-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019022911/0001213900-19-022911-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019023886/0001213900-19-023886-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019024049/0001213900-19-024049-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390019026443/0001213900-19-026443-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020001184/0001213900-20-001184-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020001186/0001213900-20-001186-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020001543/0001213900-20-001543-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020002005/0001213900-20-002005-index.htm
2020-01-305Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020002139/0001213900-20-002139-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020002565/0001213900-20-002565-index.htm
2020-02-055Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020002675/0001213900-20-002675-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020004621/0001213900-20-004621-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020004622/0001213900-20-004622-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1522602/000121390020006115/0001213900-20-006115-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020006119/0001213900-20-006119-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020007839/0001213900-20-007839-index.htm
2020-04-14PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020009118/0001213900-20-009118-index.htm
2020-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020009933/0001213900-20-009933-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020010351/0001213900-20-010351-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020011914/0001213900-20-011914-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1522602/000121390020012261/0001213900-20-012261-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020012266/0001213900-20-012266-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020012811/0001213900-20-012811-index.htm
2020-05-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1522602/000121390020013532/0001213900-20-013532-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020013534/0001213900-20-013534-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020015186/0001213900-20-015186-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020015254/0001213900-20-015254-index.htm
2020-06-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020015572/0001213900-20-015572-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020017076/0001213900-20-017076-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020021866/0001213900-20-021866-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1522602/000121390020021868/0001213900-20-021868-index.htm
2020-08-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1522602/000121390020023466/0001213900-20-023466-index.htm
2020-08-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1522602/000121390020023682/0001213900-20-023682-index.htm
2020-08-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1522602/000121390020023831/0001213900-20-023831-index.htm
2020-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1522602/000121390020023834/0001213900-20-023834-index.htm
2020-08-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024599/0001213900-20-024599-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024779/0001213900-20-024779-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024781/0001213900-20-024781-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024782/0001213900-20-024782-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024785/0001213900-20-024785-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024786/0001213900-20-024786-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020024787/0001213900-20-024787-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020025152/0001213900-20-025152-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1522602/000121390020025331/0001213900-20-025331-index.htm
2020-09-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1522602/999999999520002374/9999999995-20-002374-index.htm

CohBar, Inc (CWBR) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CohBar, Inc (CWBR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2448%
Institutional Ownership: 1234%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-06Kenneth C CundyChief Scientific OfficerSell10,000.001.9019,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm
2020-08-28DAVID GREENWOODDirectorBuy20,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020024782/0001213900-20-024782-index.htm
2020-08-06Kenneth C CundyChief Scientific OfficerBuy10,000.000.737,300.0020,000.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm
2020-08-28Misha PetkevichDirectorBuy204,918.00223,609.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020024785/0001213900-20-024785-index.htm
2020-09-02Misha PetkevichDirectorBuy6,000.001.006,000.00229,609.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020025152/0001213900-20-025152-index.htm
2020-09-03Misha PetkevichDirectorBuy11,000.001.0211,220.00240,609.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020025331/0001213900-20-025331-index.htm
2020-08-28Jon Leland SternDirectorBuy8,169.00574,151.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020024787/0001213900-20-024787-index.htm
2020-08-28ALBION FITZGERALDDirectorBuy8,196.00937,863.00https://www.sec.gov/Archives/edgar/data/1522602/000121390020024781/0001213900-20-024781-index.htm